Jellagen Pty Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Jellagen Pty Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10376
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Jellagen Pty Ltd (Jellagen) is a provider of medical grade collagen products. The company’s products offer medical grade collagen supplied in the form of hydragel used in wound dressing, soft tissue regeneration, tissue engineering and haemostats. Its product pipeline offer scaffolds, which can be used for cell culture. Jellagen also carries out research and development of type II collagen for bone diseases. The company has collaborations with universities for Nano Health for applying their electrospinning technology to electrospin the collagen into nanofibers used in medical devices. It caters to medical devices, regenerative medicine and in vitro diagnostic markets. Jellagen is headquartered in Cardiff, the UK.

Jellagen Pty Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Jellagen Pty Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Jellagen Pty Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Jellagen Pty Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Jellagen Pty Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Jellagen Pty Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Jellagen Pty Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Jellagen Raises USD2.2 Million Financing 10
Jellagen Raises USD0.93 Million in Venture Financing 11
Jellagen Raises USD0.66 Million in Venture Financing 12
Private Equity 13
Jellagen Raises USD5.3 Million in Financing 13
Partnerships 14
Collagen Solutions Enters into Research Agreement with Jellagen 14
Jellagen Pty Ltd – Key Competitors 15
Jellagen Pty Ltd – Key Employees 16
Jellagen Pty Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Jellagen Pty Ltd, Medical Equipment, Key Facts 2
Jellagen Pty Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Jellagen Pty Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Jellagen Pty Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Jellagen Pty Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Jellagen Pty Ltd, Deals By Market, 2012 to YTD 2018 8
Jellagen Pty Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Jellagen Raises USD2.2 Million Financing 10
Jellagen Raises USD0.93 Million in Venture Financing 11
Jellagen Raises USD0.66 Million in Venture Financing 12
Jellagen Raises USD5.3 Million in Financing 13
Collagen Solutions Enters into Research Agreement with Jellagen 14
Jellagen Pty Ltd, Key Competitors 15
Jellagen Pty Ltd, Key Employees 16

List of Figures
Jellagen Pty Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Jellagen Pty Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Jellagen Pty Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Jellagen Pty Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Jellagen Pty Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Jellagen Pty Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Jellagen Pty Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Jellagen Pty Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Jellagen Pty Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arkray Inc:企業の製品パイプライン分析2018
    Summary Arkray Inc (Arkray), formerly KDK Corp is a medical device company that offers diagnostic products. The company offers diagnostic products and equipments for diabetes diagnosis and urinalysis applications. Its products comprise automatic glycohemoglobin analyzer for diabetes, automated analy …
  • The Stars Group Inc (TSGI):企業の財務・戦略的SWOT分析
    The Stars Group Inc (TSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Billabong International Limited (BBG):企業の財務・戦略的SWOT分析
    Billabong International Limited (BBG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • BioView Ltd (BIOV):企業の財務・戦略的SWOT分析
    BioView Ltd (BIOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tamilnadu Petroproducts Ltd (TNPETRO):企業の財務・戦略的SWOT分析
    Summary Tamilnadu Petroproducts Ltd (TPL), a subsidiary of Southern Petrochemical Industries Corp Ltd is a petrochemical company that manufactures and markets petrochemical and related products. The company offers products such as chlorine, heavy chemicals, heavy alkylate, linear alkyl benzene, ammo …
  • Sunnova Energy Corporation:電力:M&Aディール及び事業提携情報
    Summary Sunnova Energy Corporation (Sunnova Energy) is engaged in providing solar power services to homeowners. The company is involved in installing and generating power. It offers solar service agreements such as EZ Pay PPA, PPA, EZ own plan, and solar lease plan. In addition, the company offers s …
  • Tidewater Holdings Inc:企業の戦略的SWOT分析
    Tidewater Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • McBride plc (MCB):企業の財務・戦略的SWOT分析
    McBride plc (MCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Apyx Medical Corp (BVX):企業の財務・戦略的SWOT分析
    Summary Apyx Medical Corp (Apyx Medical) formerly known as Bovie Medical Corp is a medical technology company. The company manufactures and develops cosmetic and surgical products. The company also develops J-Plasma, a helium-based plasma surgical product for cutting, coagulation and ablation of sof …
  • SandRidge Energy Inc (SD):企業の財務・戦略的SWOT分析
    SandRidge Energy Inc (SD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BEENOS Inc.:企業のM&A・事業提携・投資動向
    BEENOS Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BEENOS Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • RockBridge Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    RockBridge Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary RockBridge Resources Inc (RockBridge) is an oil and gas exploration and development company. The company acquires, develops and explores oil and gas properties. Its properties include Twinning a …
  • Air France-KLM SA:企業のM&A・事業提携・投資動向
    Air France-KLM SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Air France-KLM SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Geisinger:医療機器:M&Aディール及び事業提携情報
    Summary Geisinger formerly, Geisinger Health System is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers medical services for patients related to cardiology, ENT, gastroenterology, gynecology, cancer, …
  • Tejas Networks Ltd (TEJASNET):企業の財務・戦略的SWOT分析
    Tejas Networks Ltd (TEJASNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • GW Pharmaceuticals Plc (GWPH):製薬・医療:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Ekarat Engineering (Public) Co Ltd (AKR):企業の財務・戦略的SWOT分析
    Ekarat Engineering (Public) Co Ltd (AKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • HokBen:企業の戦略・SWOT・財務分析
    HokBen - Strategy, SWOT and Corporate Finance Report Summary HokBen - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Galapagos NV (GLPG):製薬・医療:M&Aディール及び事業提携情報
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines. The company’s clinical pipeline include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn’s disease, Phase 2 and 3 trials for ulcerati …
  • Ashok Leyland Limited:企業の戦略・SWOT・財務分析
    Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report Summary Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆